Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Xunfei Healthcare Technology CoHKSE:02506 +1.43%6 EBIT per Share is HK$-0.51 as of Jun. 2026. GuruFocus rates HKSE:02506 with a GF Score™ of 6/100. The stock has 3 warning signs investors should review. Among 525 Healthcare Providers & Services companies, Xunfei Healthcare Technology Co ranks better than 78.48% on this metric.
Xunfei Healthcare Technology Co's EBIT per Share for the
six
months ended in Jun. 2026 was HK$-0.60.
Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2026 was HK$-0.51.
During the past 3 years, the average EBIT per Share Growth Rate was 36.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Xunfei Healthcare Technology Co's EBIT per Share or its related term are showing as below:
HKSE:02506'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -10.6 Med: 12.8 Max: 36.2
Current: 36.2
During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Xunfei Healthcare Technology Co was 36.20% per year. The lowest was -10.60% per year. And the median was 12.80% per year.
HKSE:02506's 3-Year EBIT Growth Rate is ranked better than 78.48% of 525
companies
in the Healthcare Providers & Services industry
Industry Median: 11.7
vs HKSE:02506: 36.20
Xunfei Healthcare Technology Co (HKSE:02506) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Xunfei Healthcare Technology Co EBIT per Share Related Terms
Xunfei Healthcare Technology Co EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xunfei Healthcare Technology Co EBIT per Share Chart
EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.51
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xunfei Healthcare Technology Co (HKSE:02506) has a EBIT per Share of HK$-0.51 as of Jun. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Xunfei Healthcare Technology Co and its competitors. According to the industry distribution chart, Xunfei Healthcare Technology Co ranks #113 out of 525 companies in the Healthcare Providers & Services industry, placing it in the top 21.5%.
Is Xunfei Healthcare Technology Co's EBIT per Share too high?
Xunfei Healthcare Technology Co's current EBIT per Share is HK$-0.51. Based on the distribution chart, Xunfei Healthcare Technology Co ranks #113 out of 525 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Xunfei Healthcare Technology Co has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Xunfei Healthcare Technology Co's EBIT per Share compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Xunfei Healthcare Technology Co ranks #113 out of 525 companies for EBIT per Share. This places Xunfei Healthcare Technology Co in the top 22% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 11.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.70, based on 525 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Xunfei Healthcare Technology Co and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Xunfei Healthcare Technology Co's current EBIT per Share is HK$-0.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xunfei Healthcare Technology Co stock overvalued right now?
Xunfei Healthcare Technology Co (HKSE:02506) has a current EBIT per Share of HK$-0.51. The current EBIT per Share is HK$-0.51. Xunfei Healthcare Technology Co's overall GF Score™ is 6/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Xunfei Healthcare Technology Co (HKSE:02506), the current EBIT per Share is HK$-0.51 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AddressNo. 666 Science and Innovation Road, High-tech Zone, 4 to 5/F (North Area), No.1 Building, Anhui Province, iFLYTEK AI Research and Development Production Bas, Chengxiqiao Community Services Center, Hefei, CHN
Xunfei Healthcare Technology Co Ltd is an AI-empowered healthcare solution provider, offering products and solutions that support a range of healthcare services, ranging from health risk warnings, early screening, auxiliary diagnosis and treatment, and treatment effect evaluation, to post-discharge management and chronic disease management. The company has independently developed AI technologies that underpin its products and solutions including Smart Healthcare, Smart Hospital, Smart Hardware, Smart Medical Insurance, and Smart Film Union.
6GF Score
Get the complete analysis for HKSE:02506
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02506 has been successfully added to your 
